SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kieron South, Brenda M. Luken, James T. B. Crawley, Rebecca Phillips, Mari Thomas, Richard F. Collins, Louis Deforche, Karen Vanhoorelbeke, David A. Lane, Conformational activation of ADAMTS13, Proceedings of the National Academy of Sciences, 2014, 111, 52, 18578

    CrossRef

  2. 2
    H. B. Feys, B. Aelst, K. Devreese, R. Devloo, J. Coene, P. Vandekerckhove, V. Compernolle, Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion, Vox Sanguinis, 2014, 106, 4
  3. 3
    I. Mackie, K. Langley, A. Chitolie, R. Liesner, M. Scully, S. Machin, F. Peyvandi, Discrepancies between ADAMTS13 activity assays in patients with thrombotic microangiopathies, Thrombosis and Haemostasis, 2013, 109, 3, 488

    CrossRef

  4. 4
    Vincent Peigne, Elie Azoulay, Isaline Coquet, Eric Mariotte, Michael Darmon, Paulette Legendre, Nadir Adoui, Anne Marfaing-Koka, Martine Wolf, Benoit Schlemmer, Agnès Veyradier, The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation, Critical Care, 2013, 17, 6, R273

    CrossRef

  5. 5
    J. T. B. Crawley, M. A. Scully, Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies, Hematology, 2013, 2013, 1, 292

    CrossRef

  6. 6
    J. T. B. Crawley, R. de Groot, Y. Xiang, B. M. Luken, D. A. Lane, Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor, Blood, 2011, 118, 12, 3212

    CrossRef